Endoscopic ultrasound-guided ablation of small pancreatic neuroendocrine neoplasms: Bridging the gap between surveillance and surgery

Figure 1 Proposed decision-making algorithm for the management of small pancreatic neuroendocrine neoplasms. Endoscopic ultrasound-guided therapies should be considered only in carefully selected patients after assessment of tumor biology, anatomical feasibility, surgical risk, acceptability of surveillance, and patient preference. The algorithm is intended as a pragmatic framework for multidisciplinary discussion and should not be regarded as a validated clinical guideline. EUS: Endoscopic ultrasound; panNEN: Pancreatic neuroendocrine neoplasm; CT: Computed tomography; MRI: Magnetic resonance imaging; CE: Contrast-enhanced.